Clearside shares jump as reformulated TKI drug passes mid-stage test in wet AMD

Clearside Biomedical reported positive results from a Phase 2b trial of its tyrosine kinase inhibitor in patients with wet age-related macular degeneration, bolstering its prospects …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

STRATEC REPORTS CHANGES IN FINANCE DIVISION – Biotech Investments

EQS-News: STRATEC SE / Key word(s): Personnel STRATEC REPORTS CHANGES IN FINANCE DIVISION 30.07.2024 / 09:55 CET/CEST The issuer is solely responsible for the content

July 31, 2024

FDA grants orphan drug designation to ImPact’s focal cancer therapy

The FDA has granted an orphan drug designation to ImPact’s Bio’s padeliporfin VTP for patients with locally advanced pancreatic cancer. Credit: Shutterstock / Nemes Laszlo.

July 6, 2023

Elsevier Health Launches AI-Powered Clinical Decision Support Tool

What You Should Know: – Elsevier Health, a global leader in medical information and data analytics, announced the launch of ClinicalKey AI, the first and

March 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.